| 摘要 |
<p>Methods of treating and/or preventing disorders mediated by one or more of TNF-a, NF- ?B, IKK-a, IKK-ß, ATF-2 and p38 kinase by administration of praziquantel, or a pharmaceutically acceptable salt, prodrug, ester or amide thereof. These disorders include inflammatory disorders such as autoimmune diseases.</p> |
| 申请人 |
GENCROSS, INC.;SHIN, DEUG, YONG;CHOI, TAE, SAENG;JIN, DONG, HOON;CHO, MIN, KYUNG |
发明人 |
SHIN, DEUG, YONG;CHOI, TAE, SAENG;JIN, DONG, HOON;CHO, MIN, KYUNG |
